A Phase 2b Study of Zagociguat in Patients With MELAS

Clinical trial NCT06402123 · COMPLETED

Trial details

NCT number: NCT06402123
Sponsor: Tisento Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)

Start date: 2024-09-10
Primary completion: 2026-06-29
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.